Hello all. First post. I’m 54, dx with Gleason 9, PSA 45; RP with ePLND September 2021; Stage IVA, pT3bN1cM0; EPE, positive margin, SVI, 8/27 + LNs with LVI, microscopic bladder neck invasion. Persistent PSA six weeks post RP @ 4.0. ADT+abi started November 2021, with rapid PSA response. Has been <0.01 since January 2022. IMRT x40, to whole pelvis with boosts to bed and anastomosis January through March 2022.
No PSMA imaging. Conventional scans and fluciclovine scans in August 2021, repeated December 2021, didn’t reveal any bone or visceral Mets.
Thanks to this site, I’ve learned of the two recent triplet therapy studies. With my LN+ disease, but with presumptive micromets, would triplet therapy benefit me?
Comments from all are welcome, but particularly from Tall Allen, hopefully.
Thank you,
Henry